Delayed booster dosing improves human antigen-specific Ig and B
Por um escritor misterioso
Descrição
medRxiv - The Preprint Server for Health Sciences
Viruses, Free Full-Text
Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
Frontiers mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection
Vaccines, Free Full-Text
Frontiers mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses
Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after with mRNA but not adenovirus priming
PDF) Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
Peptides for Vaccine Development
Immuno, Free Full-Text
Single-cell RNA-Seq of antigen-specific B cells from DFx and
PDF) Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
Frontiers Low switched memory B cells are associated with no humoral response after SARS-CoV-2 vaccine boosters in kidney transplant recipients
de
por adulto (o preço varia de acordo com o tamanho do grupo)
